Walleye Trading’s ChemoCentryx, Inc. CCXI Stock Holding History

Walleye Trading’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-14,800	Closed	-$765K	–	5800
2022 Q3	$765K	Buy	14,800 +5,200	+54%	+$215K	﹤0.01%	2488
2022 Q2	$238K	Sell	9,600 -17,300	-64%	-$381K	﹤0.01%	3559
2022 Q1	$674K	Sell	26,900 -8,700	-24%	-$244K	﹤0.01%	2611
2021 Q4	$1.3M	Buy	35,600 +9,900	+39%	+$348K	﹤0.01%	2012
2021 Q3	$439K	Buy	+25,700	New	+$400K	﹤0.01%	3046
2021 Q1	–	Sell	-8,600	Closed	-$533K	–	5519
2020 Q4	$533K	Buy	8,600 +5,300	+161%	+$303K	﹤0.01%	2600
2020 Q3	$181K	Buy	+3,300	New	+$178K	﹤0.01%	3062

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Walleye Trading's CCXI Position: Q4 2022 in Review

Walleye Trading sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 45,348 shares — an estimated $2.34M sold.

Walleye Trading first reported a position in CCXI in Q4 2016 and held it in 10 quarters. The position peaked at $2.34M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Walleye Trading reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Walleye Trading sold 45,348 ChemoCentryx, Inc. shares in Q4 2022, an estimated $2.34M.
Walleye Trading first reported a position in ChemoCentryx, Inc. in Q4 2016 and held it in 10 quarters.
Walleye Trading's ChemoCentryx, Inc. position peaked at $2.34M in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Walleye Trading's 13F filing for Q4 2022, filed 14 Feb 2023.